Tenax Therapeutics Stock Forward View
| TENX Stock | USD 12.01 0.26 2.21% |
Tenax Stock outlook is based on your current time horizon.
At this time, the RSI of Tenax Therapeutics' share price is approaching 47. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Tenax Therapeutics, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (1.40) | EPS Estimate Current Year (1.37) | EPS Estimate Next Year (1.57) | Wall Street Target Price 22.904 | EPS Estimate Current Quarter (1.12) |
Using Tenax Therapeutics hype-based prediction, you can estimate the value of Tenax Therapeutics from the perspective of Tenax Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Tenax Therapeutics on the next trading day is expected to be 12.90 with a mean absolute deviation of 0.64 and the sum of the absolute errors of 39.08. Tenax Therapeutics after-hype prediction price | USD 12.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Tenax Therapeutics to cross-verify your projections. Tenax Therapeutics Additional Predictive Modules
Most predictive techniques to examine Tenax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tenax using various technical indicators. When you analyze Tenax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Tenax Therapeutics' financial statements to predict how it will affect future prices.
Cash | First Reported 1996-09-30 | Previous Quarter 105.5 M | Current Value 99.4 M | Quarterly Volatility 20.3 M |
Tenax Therapeutics Naive Prediction Price Forecast For the 28th of February
Given 90 days horizon, the Naive Prediction forecasted value of Tenax Therapeutics on the next trading day is expected to be 12.90 with a mean absolute deviation of 0.64, mean absolute percentage error of 0.81, and the sum of the absolute errors of 39.08.Please note that although there have been many attempts to predict Tenax Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Tenax Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Tenax Therapeutics Stock Forecast Pattern
| Backtest Tenax Therapeutics | Tenax Therapeutics Price Prediction | Research Analysis |
Tenax Therapeutics Forecasted Value
In the context of forecasting Tenax Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Tenax Therapeutics' downside and upside margins for the forecasting period are 7.59 and 18.20, respectively. We have considered Tenax Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Tenax Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Tenax Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.8944 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.6406 |
| MAPE | Mean absolute percentage error | 0.0487 |
| SAE | Sum of the absolute errors | 39.0762 |
Predictive Modules for Tenax Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tenax Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tenax Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Tenax Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tenax Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tenax Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Tenax Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Tenax Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tenax Therapeutics' historical news coverage. Tenax Therapeutics' after-hype downside and upside margins for the prediction period are 7.13 and 17.83, respectively. We have considered Tenax Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Tenax Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Tenax Therapeutics is based on 3 months time horizon.
Tenax Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Tenax Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tenax Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tenax Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.54 | 5.30 | 0.69 | 0.00 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.01 | 12.48 | 6.21 |
|
Tenax Therapeutics Hype Timeline
Tenax Therapeutics is at this time traded for 12.01. The entity has historical hype elasticity of 0.69, and average elasticity to hype of competition of 0.0. Tenax is estimated to increase in value after the next headline, with the price projected to jump to 12.48 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 6.21%, whereas the daily expected return is at this time at 0.54%. The volatility of related hype on Tenax Therapeutics is about 176666.67%, with the expected price after the next announcement by competition of 12.01. Given the investment horizon of 90 days the next estimated press release will be in about 8 days. Check out Historical Fundamental Analysis of Tenax Therapeutics to cross-verify your projections.Tenax Therapeutics Related Hype Analysis
Having access to credible news sources related to Tenax Therapeutics' direct competition is more important than ever and may enhance your ability to predict Tenax Therapeutics' future price movements. Getting to know how Tenax Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tenax Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VRCA | Verrica Pharmaceuticals | 0.09 | 5 per month | 5.01 | 0.08 | 12.57 | (9.24) | 52.65 | |
| SABS | SAB Biotherapeutics | (0.03) | 6 per month | 3.43 | 0.02 | 5.35 | (5.80) | 16.22 | |
| QTTB | Q32 Bio | 0.04 | 5 per month | 4.02 | 0.16 | 9.56 | (7.66) | 85.16 | |
| ANTX | AN2 Therapeutics | (0.07) | 9 per month | 3.16 | (0.02) | 5.56 | (4.58) | 32.31 | |
| JSPR | Jasper Therapeutics | (0.01) | 6 per month | 0.00 | (0.07) | 7.89 | (8.06) | 31.75 | |
| NXTC | NextCure | 0.04 | 4 per month | 3.71 | 0.09 | 8.77 | (6.41) | 43.11 | |
| PSTV | Plus Therapeutics | (0.01) | 7 per month | 0.00 | (0.07) | 9.43 | (8.82) | 48.30 | |
| BOLD | Boundless Bio Common | (0.01) | 5 per month | 2.11 | (0.02) | 4.24 | (3.67) | 16.75 | |
| PLUR | Pluri Inc | (0.06) | 6 per month | 3.94 | 0.01 | 9.90 | (5.25) | 22.62 | |
| NERV | Minerva Neurosciences | (0.01) | 8 per month | 4.50 | 0.10 | 12.31 | (9.09) | 25.06 |
Other Forecasting Options for Tenax Therapeutics
For every potential investor in Tenax, whether a beginner or expert, Tenax Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Tenax Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Tenax. Basic forecasting techniques help filter out the noise by identifying Tenax Therapeutics' price trends.Tenax Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tenax Therapeutics stock to make a market-neutral strategy. Peer analysis of Tenax Therapeutics could also be used in its relative valuation, which is a method of valuing Tenax Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Tenax Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Tenax Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tenax Therapeutics shares will generate the highest return on investment. By undertsting and applying Tenax Therapeutics stock market strength indicators, traders can identify Tenax Therapeutics entry and exit signals to maximize returns.
Tenax Therapeutics Risk Indicators
The analysis of Tenax Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Tenax Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting tenax stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.88 | |||
| Semi Deviation | 4.15 | |||
| Standard Deviation | 5.32 | |||
| Variance | 28.34 | |||
| Downside Variance | 21.25 | |||
| Semi Variance | 17.25 | |||
| Expected Short fall | (4.40) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Tenax Therapeutics
The number of cover stories for Tenax Therapeutics depends on current market conditions and Tenax Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Tenax Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Tenax Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Tenax Therapeutics Short Properties
Tenax Therapeutics' future price predictability will typically decrease when Tenax Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Tenax Therapeutics often depends not only on the future outlook of the potential Tenax Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tenax Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.3 M | |
| Cash And Short Term Investments | 94.9 M |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.